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Excess Visceral
Adipose Tissue/Ectopic Fat
The Missing Link in the Obesity Paradox?*
Jean-Pierre Després, PHD
Québec City, Québec, Canada
Although obesity is recognized as a health hazard that has
reached epidemic proportions in affluent and emerging
economies (1,2), the strength of its relationship with coro-
nary heart disease (CHD) and related mortality has been
shown to be variable and inconsistent (3). Two main factors
could explain these findings: 1) most of the risk attributed to
obesity could be mediated by its related cardiometabolic
abnormalities (dyslipidemia, hypertension, insulin resistance
and diabetes, inflammation, pro-thrombotic profile, and the
like) (4); 2) obesity is most often diagnosed in clinical
practice by a simple anthropometric variable, the body mass
index (BMI), which is the ratio of weight (in kilograms)
over height (in meters squared). Although useful to describe
the secular changes in the prevalence of obesity at the
population level, the BMI only provides a crude measure-
ment of total adiposity. Furthermore, in all individuals and
patients, the BMI is a totally inadequate index of regional
body fat distribution, the latter phenotype being critically
important in patients with CHD, as nicely shown by the
report by Coutinho et al. (5) published in this issue of the
Journal.
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Although prospective studies have shown a univariate
relationship between BMI and incidence of a first CHD
event and related mortality (6,7), the picture became quite
blurry among patients with documented CHD when it was
counterintuitively reported that a high BMI was predictive
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been commonly referred to as the “obesity paradox” in
cardiology (8,9). The report by Coutinho et al. (5) has
finally shed some light on this question and should
hopefully spur further studies where investigators will
consider going beyond the BMI to assess the morbidity/
mortality risk associated with excess adiposity in patients
with CHD. Indeed, the report provides robust evidence
that anthropometric correlates of body shape, such as
waist circumference and the waist-to-hip circumference
ratio, matter a lot more in cardiology than the BMI,
which is only an index of relative body size and not of
body composition/fat distribution.
For more than 2 decades, a plethora of studies has clearly
shown that the distribution of body fat, especially excess
abdominal fat accumulation (which can be crudely esti-
mated by the measurement of waist circumference), is
predictive of both prevalent and incident CHD and type 2
diabetes—this relationship being largely independent from
the contribution of total body fat to risk (10–15). In their
report, Coutinho et al. (5) have meticulously scrutinized the
published data and combined individual data from previ-
ously published studies with their own unpublished obser-
vations. They reached the important conclusion that, al-
though an elevated BMI was indeed associated with reduced
mortality risk in patients with CHD, a totally different
picture emerged when waist circumference was used as an
index of abdominal obesity: an elevated waist circumference
and a high ratio of waist over hip circumferences were
associated with increased mortality risk in CHD patients.
These results are very important for the field of cardiol-
ogy, because they will clear the confusion around the
prognostic value of obesity and emphasize the need to go
beyond the BMI as the preferred anthropometric index of
adiposity. From these results, we should also question why,
in patients with CHD, a large waistline has a fundamentally
different relationship with mortality than relative weight.
Furthermore, although waist circumference has been advo-
cated as an index of abdominal obesity, it is important to
point out that it should not replace the BMI as the single
adiposity index. For instance, when a large population-
based sample is examined, considerable variation in the
distribution of BMI values is obviously found. In such large
and heterogeneous samples, a strong correlation (of about
0.8 to 0.9) between the BMI and waist girth is systemati-
cally observed (16). Thus, it has been argued by some that
BMI and waist circumference could be interchangeable
indexes of adiposity and that there would be no need to
measure waist circumference once BMI had been assessed
(17–19). Although this is a reasonable point at the popula-
tion level, Figure 1 shows that waist and BMI are not
interchangeable at the individual/patient level. Figure 1
shows median waist circumference values for every individ-
ual BMI unit in the subgroup of 64,624 men of the IDEA
(International Day for the Evaluation of Abdominal Obe-
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(20). Although progressively higher median waist values
were associated with increasing BMI units, the box-and-
whisker plots clearly indicate that, for any given BMI value,
the variation in waist circumference was considerable with a
mean waist range of 9.43 cm between the 25th and 75th
percentiles. Thus, although waist circumference and BMI
are strongly correlated at the population level, in clinical
practice, cardiologists should expect to find substantial
individual variation in waist circumference among their
patients with similar BMI values.
The implications of these observations are not trivial:
waist circumference should not replace the BMI in cardi-
ology, because it has to be interpreted in the context of the
BMI. For example, compare 2 patients who have exactly the
same waist circumference value (103 cm): Patient #1 has a
BMI of 25 kg/m2, whereas Patient #2 has a BMI of 30
g/m2. Thus, had only the waist been measured, the
clinician would have missed tremendously important infor-
mation: Patient #2 has a large waistline because he has
overall obesity, whereas Patient #1 is not obese but clearly
has an excess of abdominal fat. This observation could
explain why, in the meta-analysis of Coutinho et al. (5), a
large waist circumference was particularly predictive of
increased mortality among patients with presumably “nor-
mal” BMI values. These patients might have less muscle
mass, have a poor cardiorespiratory fitness, and most im-
portantly, be characterized by an excess of intra-abdominal
(visceral) adipose tissue and by increased ectopic fat depo-
sition for which excess liver fat and epi/pericardial fat are
salient features (16). In patients asymptomatic for CHD, it
Figure 1 Waist and BMI Are Not Interchangeable
at the Individual/Patient Level
Box-and-whisker plots showing the distribution of waist circumference values
(age-adjusted) per unit of body mass index (BMI) in the subsample of 64,624
men of the IDEA (International Day for the Evaluation of Abdominal Obesity)
study (20) who had BMI values 20 and 40 kg/m2. Data shown are medi-
ans, quartiles, and 10th and 90th percentiles.has been shown that excess visceral adipose tissue/liver fatdeposition is clearly the adiposity phenotype associated with
the most severe diabetogenic and atherogenic metabolic
abnormalities (4,16). Although the study by Coutinho et al.
(5) only used anthropometric markers of what they referred
to as “central obesity,” their results question the relevance of
only measuring the BMI in cardiology. Clearly, body shape
and how regional adipose tissue handles and stores excess
dietary energy have tremendous cardiometabolic implica-
tions. As suggested by Poirier (21), BMI is now to anthro-
pometry what “total cholesterol” was to lipidology. The
report by Coutinho et al. (5) clearly indicates that it is time
to move on to better assessment tools. From the work that
we have conducted over the last 25 years, it is suggested that
further attention should be given to patients who have an
exaggerated waistline for their BMI, particularly if this large
waistline is accompanied by elevated triglyceride levels as a
marker of excess visceral adipose tissue/ectopic liver fat
deposition. It is proposed that excess visceral adiposity/
ectopic fat identified in clinical practice by “hypertriglycer-
idemic waist” (22,23) is the clue to what was never an
“obesity paradox” but rather a “BMI paradox.”
Reprint requests and correspondence: Dr. Jean-Pierre Després,
Centre de recherche de l’Institut universitaire de cardiologie et de
pneumologie de Québec, Pavilion Marguerite-D’Youville, Fourth
Floor, 2725 chemin Ste-Foy, Québec G1V 4G5, Canada. E-mail:
jean-pierre.despres@criucpq.ulaval.ca.
REFERENCES
1. Ford ES, Mokdad AH. Epidemiology of obesity in the Western
Hemisphere. J Clin Endocrinol Metab 2008;93:S1–8.
2. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular
disease: pathophysiology, evaluation, and effect of weight loss: an
update of the 1997 American Heart Association Scientific Statement
on Obesity and Heart Disease from the Obesity Committee of the
Council on Nutrition, Physical Activity, and Metabolism. Circulation
2006;113:898–918.
3. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of
overweight with increased risk of coronary heart disease partly inde-
pendent of blood pressure and cholesterol levels: a meta-analysis of 21
cohort studies including more than 300 000 persons. Arch Intern Med
2007;167:1720–8.
4. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard
C. Regional distribution of body fat, plasma lipoproteins, and cardio-
vascular disease. Arteriosclerosis 1990;10:497–511.
5. Coutinho T, Goel K, Corrêa de Sa´ D, et al. Central obesity and
survival in subjects with coronary artery disease: a systematic review of
the published data and collaborative analysis with individual subject
data. J Am Coll Cardiol 2011;57:1877–86.
6. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and
mortality among women. N Engl J Med 1995;333:677–85.
7. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change,
and coronary heart disease in women. Risk within the ‘normal’ weight
range. JAMA 1995;273:461–5.
8. Romero-Corral A, Montori VM, Somers VK, et al. Association of
bodyweight with total mortality and with cardiovascular events in
coronary artery disease: a systematic review of cohort studies. Lancet
2006;368:666–78.
9. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular
disease: risk factor, paradox, and impact of weight loss. J Am Coll
Cardiol 2009;53:1925–32.
10. Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and
risk of coronary heart disease in men and women in the European
Prospective Investigation Into Cancer and Nutrition in Norfolk
11
1
1
1
1
1
1
1
2
2
2
2
1889JACC Vol. 57, No. 19, 2011 Després
May 10, 2011:1887–9 Visceral/Ectopic Fat and the Obesity Paradoxcohort: a population-based prospective study. Circulation 2007;116:
2933–43.
1. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L.
Distribution of adipose tissue and risk of cardiovascular disease and
death: a 12 year follow up of participants in the population study of
women in Gothenberg, Sweden. Br Med J 1984;289:1257–61.
2. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P,
Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of
cardiovascular disease and death: 13 year follow-up of participants in
the study of men born in 1913. Br Med J 1984;288:1401–4.
3. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat
distribution on the incidence of diabetes mellitus: 13.5 years of
follow-up of the participants in the study of men born in 1913.
Diabetes 1985;34:1055–8.
4. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity
and coronary heart disease in women. JAMA 1998;280:1843–8.
5. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of
myocardial infarction in 27,000 participants from 52 countries: a
case-control study. Lancet 2005;366:1640–9.
6. Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the
metabolic syndrome: contribution to global cardiometabolic risk.
Arterioscler Thromb Vasc Biol 2008;28:1039–49.7. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat:
where is the ‘beef’? Int J Obes (Lond) 2007;31:1552–3.8. Farin HM, Abbasi F, Reaven GM. Body mass index and waist
circumference correlate to the same degree with insulin-mediated
glucose uptake. Metabolism 2005;54:1323–8.
9. Kiernan M, Winkleby MA. Identifying patients for weight-loss
treatment: an empirical evaluation of the NHLBI obesity education
initiative expert panel treatment recommendations. Arch Intern Med
2000;160:2169–76.
0. Balkau B, Deanfield JE, Després JP, et al. International Day for the
Evaluation of Abdominal Obesity (IDEA): a study of waist circum-
ference, cardiovascular disease, and diabetes mellitus in 168,000
primary care patients in 63 countries. Circulation 2007;116:1942–51.
1. Poirier P. Adiposity and cardiovascular disease: are we using the right
definition of obesity? Eur Heart J 2007;28:2047–8.
2. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist. A
marker of the atherogenic metabolic triad (hyperinsulinemia, hyper-
apolipoprotein B, small, dense LDL) in men? Circulation 2000;102:
179–84.
3. Lemieux I, Poirier P, Bergeron J, et al. Hypertriglyceridemic waist: a
useful screening phenotype in preventive cardiology? Can J Cardiol
2007;23:23B–31B.Key Words: central obesity y coronary artery disease y mortality y
waist circumference y waist-hip ratio.
